Snapshot from Sep 13, 2026 at 07:00 UTC. For live data and tracking: View Live
Business product launch

DataMeds AI launches Galectovid for cold and flu season

Analysis based on 10 articles · First reported Aug 27, 2026 · Last updated Aug 27, 2026

Sentiment
10
Attention
1
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The launch may boost DataMeds AI's revenue and market presence in the OTC cold and flu segment, potentially positively impacting its stock. Tollo Health and Corexa Pharmacy may see increased sales, while Amazon (company) could benefit from distribution.

Healthcare Pharmaceuticals Biotechnology

DataMeds AI, Inc. (NASDAQ:MEDS) announced the U.S. direct-to-consumer launch of Galectovid, a medical food for the dietary management of galectin-1 and galectin-3 associated viral infections, for the 2026 Cold & Flu Season. The product is available over-the-counter at Tollo Health's online store and at DataMeds AI's wholly-owned pharmacy Corexa Pharmacy's online store, with plans to expand to Health Lives Here pharmacies and Amazon (company). Galectovid is categorized as a medical food under the Orphan Drug Act and its ingredients are on the FDA's Generally Recognized as Safe list. The company is offering a 50% discount through its #Back2School50% campaign. Interim co-CEO Gerald Commissiong expressed confidence in the product and noted expansion of research activities through physician relationships.

100 DataMeds AI launched
70 DataMeds AI partnered with Tollo Health
40 DataMeds AI expanded research
priv
DataMeds AI is the primary company launching Galectovid, which could drive revenue and strengthen its product portfolio. The launch may positively affect its stock price and market perception.
Importance 100.0 Sentiment 20.0
priv
Tollo Health is the partner that developed Galectovid and sells it through its online store, benefiting from increased distribution and sales.
Importance 70.0 Sentiment 15.0
priv
Corexa Pharmacy, a subsidiary of DataMeds AI, distributes Galectovid through its online store, contributing to the product's availability and sales.
Importance 50.0 Sentiment 10.0
per
Gerald Commissiong, interim co-CEO, is the spokesperson for the launch, representing the company's leadership and strategic direction.
Importance 30.0 Sentiment 5.0
stock
Amazon (company) is expected to become a distribution channel for Galectovid, potentially increasing its sales and market reach.
Importance 30.0 Sentiment 5.0
govactor
The FDA's GRAS designation for Galectovid's ingredients provides regulatory compliance, but the FDA is not directly impacted by the launch.
Importance 20.0 Sentiment 0.0
DataMeds AI acquirer ↔ Tollo Health DataMeds AI has entered into a non-binding letter of intent to acquire a controlling interest in Tollo Health and is act
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.